Moberg Derma
Bromma
About Moberg Derma
Moberg Pharma is a rapidly growing Swedish pharmaceutical company that commercializes proprietary, acquired and licensed products in the global market. They create value for patients, physicians and owners by offering products based on proven compounds, which have better efficacy, fewer side effects or are easier to use. Initially, Moberg Pharma specialized in the treatment of skin diseases but is now widening its scope to include additional areas. They market OTC brands in the U.S. and sell through distributors in more than 35 countries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2020)
- Ticker: sto:MOB
- Website: mobergpharma.se
- Phone: 9739467560
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/moberg-derma-106683 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.